Drug Interactions Corner

Back to articles

PPIs decrease antifracture efficacy of bisphosphonates

KEY POINT

 In a study recently published online in Archives of Internal Medicine, researchers found that the concurrent use of PPIs with alendronate (Fosamax—Merck) decreased the antifracture efficacy of bisphosphonate.